Monkey-pox, a model of emergent then reemergent disease;Le monkey-pox, un paradigme de maladie émergente puis réémergente

Medecine et Maladies Infectieuses

Volumn 34, Issue 1, 2004, Pages 12-19

  Georges, A J ^a   Matton, T ^b   Courbot Georges, M C ^c  

^a Hopital d'Instruction des Armees Legouest   (France)

^b Serv de Med des Collectivites   (France)

^c Institut Pasteur   (France)

Author keywords

Bioterrorism; Monkey pox; Pox vaccine; Pox virus

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; MONKEYPOX VACCINE; RIBAVIRIN;

AFRICA; BIOLOGICAL WARFARE; CLINICAL FEATURE; CONGO; DEATH; DIAGNOSTIC PROCEDURE; EPIDEMIC; GAMBIA; HUMAN; IMMUNOTHERAPY; MONKEY; MONKEYPOX; MONKEYPOX VIRUS; NONHUMAN; REVIEW; RODENT; SCREENING; SPECIES; SQUIRREL; THREAT; UNITED STATES; VACCINATION; ZOONOSIS;

EID: 1642451972     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2003.09.008     Document Type: Short Survey

References (64)

1. o 6:1988;World Health Organization, Geneva.
2. Breman J.G., Arita I. The confirmation and maintenance of smallpox eradication. N Engl J Med. 303:1980;1263-1273.
3. Georges A.-J., Georges Courbot M.C. Les biorisques liés aux orthopoxvirus : faut-il revacciner contre la variole ? Med Trop. 59:1999;483-487.
4. o 49, q agenda item 18.1. Sixth plenary meeting a49/vr/6. 1996;Wolrd Health Organization, Geneva.
5. Breman J.G., Henderson D. Poxvirus dilemmas: monkey-pox, smallpox and biologic terrorism. N. Engl. J. Med. 339:(8):1998;556-559.
6. Mukinda V.B., Mwema G., Kilundu M., et al. Reemergence of monkey-pox in Zaïre in 1996. Lancet. 349:1997;1449-1450.
7. Fine P.E., Jezek Z., Grab B., Dixon H. The transmission potentiel of monkey-pox virus in human populations. Int J Epidémiol. 17:(3):1988;643-650.
8. Jezek Z., Marrennikova S.S., Mutumbo M., Nakano J.H., Nakano J.H., Palaku K.M., et al. Human monkey-pox: a study of 2510 contacts of 214 patients. J Infect Dis. 154:(4):1986 oct;551-555.
9. Cohen J. Is an old virus up to new tricks? Science. 277:1997;312-313.
10. Ladnyj I., Ziegler P., Kima E. A human infection caused by monkey-pox virus in Basankusu territory, democratic republic of the Congo. Bull. World Health Organ. 46:1972;593-597.
11. Wenner H.A., Bolano C.R., Cho C.T., Kamitsuka P.S. Studies on the pathogenesis of monkey-pox. iii. Histopathological lesions and sites of immunofluorescence. Arch Ges Virusforsch. 27:1969;179-197.
12. Stagles M.J., Watson A.A., Boyd J.F., More J.A.R., Mcseveney D. The histopathology and electron microscopy of a human monkey-pox lesion. Trans R Soc Trop Med Hyg. 79:1985;192-202.
13. Human monkey-pox in Kasai Oriental, Zaire (1996-1997). MMWR. 46:1997;304-307. (erratum mmwr, 1997; 46: 706).
14. Human monkey-pox in Kasai Oriental, Zaire (1996-1997). Wkly Epidemiol. Rec. 72:1997;101-104.
15. Human monkey-pox in Kasaï Oriental, democratic republic of Congo (former Zaïre): preliminary report of october 1997 investigation. Wkly Epidemiol Rec. 72:1997;369-372.
16. Mwanba P.T., Tshioko K., Mondi A., et al. Des cas humains d'orthopoxvirose simienne au Kasaï Oriental, Zaïre (1996-1997). Euro Surveillance. 2:1997;33-35.
17. Mwamba P.T., TshioKo K.F., Moudi A., Mukinda V., Mwema G.N., Messinger D., et al. Human monkey-pox in Kasaï Oriental, Zaire (1996-1997). MMWR. 46:(14):1997;204-208.
18. o 3):1998;693-770.
19. Breman J.G., Kalisa-Ruti J., Atienowski M.Y., Saneta E., Gormyco A.E., Arita I. Human monkey-pox 1970-1979. Bull. World Health Organ. 58:(165):1980;82.
20. Jezek Z., Grab B., Szczeniowski M.Y., Paluku K.M., Murunbo M., Fenner E. Human monkey-pox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Bull. World Health Organ. 66:1988;465-470.
21. Meyer H., Perrichot M., Stemmler M., Emmerich P., Schmitz H., Vara F., et al. Outbreaks of disease suspected of being due to human monkey-pox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol. 40:(8):2002;2919-2921.
22. Reed K., Melski J., Stratman E. Index case and family infection of monkey-pox from prairie dogs diagnosed in marshfield, wi (electron micrographs).Marshfield clinic Illinois. :may-june 2003;
23. Update Multistate outbreak of monkey-pox - Illinois, Indiana, Kansas, Missouri, Ohio and Wisconsin, 2003. MMWR. 52:2003;616-618.
24. Fenner F. Pox viruses. 3rd edition Fields B.N., Knipe D.M., Howley P.M., et al. Fields virology. 1996;2674-2702 Lippingott - Raven publishers, Philadelphia.
25. Fenner F. Adventures with poxviruses of vertebrates. Fems Microbiology Reviews. 2:2000;123-133.
26. Shchelkunov N., Totmenin V., Babkin V., Safronov F., Ryazankina I., Petrov A., et al. Human monkey-pox and smallpox viruses: genomic comparison. Febs letters. 509:2001;66-70.
27. Douglas N.J., Dumbell K.R. - DNA sequence variation as a clue to the phylogenesis of orthopoxviruses. J. Gen. Virol. 77:1996;947-951.
28. Ryazankina O.I., Valery V., Nicolai A.J., Petrov V.T., Gutorovt V., Elena A.O., et al. Human monkey-pox and smallpox viruses: genomic comparison. Febs letters. 509:2001;66-70.
29. Jezek Z., Fenner E. Human monkey pox,. vol. 17. Monographs in virology. 1988;. Basel, Switzerland.
30. Breman J.G. Monkey-pox: an emerging infection in humans? Chapter in emerging infections (4). Scheld W.M., Craig W.A., Hughes J.M. 200 ASM. 200:2001;Press, Washington Dc.
31. Hutin Y.J., Williams R.J., Malfait P., Pebody R., Loparev V.N., Ropp S.L., et al. Outbeak of human monkey-pox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 7:(3):2001;434-438.
32. Arita I., Jezek Z., Khodadekevich L., Ruti K. Human monkey-pox: a newly emerged orthopoxvirus zoonosis in the tropical rain forest of Africa. Am J Trop Med Hyg. 34:(4):1985 jul;781-789.
33. Monkey-pox, human, prairie dogs - USA (Wisconsin, Illinois, Indiana) ProMed Mail, in "promed-edr@promedmail.org", 8 juin 2003-07-30 no 20030608.1412.
34. Monkey-pox, human, prairie dogs - USA (Wisconsin, Illinois, Indiana) ProMed Mail, in "promed-edr@promedmail.org, 9 juin 2003 no 20030609.1422.
35. Update Multistate outbreak of monkey-pox - Illinois, Indiana, Kansas, Missouri, Ohio and Wisconsin, 2003. MMWR. 52:2003;589-590.
36. Update Multistate outbreak of monkey-pox - Illinois, Indiana, Kansas, Missouri, Ohio and Wisconsin, 2003. MMWR. 52:2003;561-564.
37. Multistate outbreak of monkey-pox - Illinois, Indiana, And Wisconsin, 2003. MMWR. 52:2003;537-540.
38. Gage K.L., Thomas R.E., Montenieri J.A. The role of predators in the ecology, epidemiology, and surveillance of plague in the United States. Proceedings of the 16th vertebrate pest conference. 1994;200-206 University of California, Davis California.
39. Reptile associated salmonellosis - selected states (1996-1998). MMWR. 48:1999;1009-1013.
40. Outbreak of tularemia among commercially distributed prairies dogs 2002. MMWR. 51:2002;688-699.
41. Institute of medicine. Microbial threats to health: emergence, detection, and response, 2003. 2003;National Academies Press, Washington, DC.
42. o 12):2001;581.
43. Bray M., Martinez M., Smee D.F., Kefauver D., Thompson E., Huggins J.W. Cidofovir protects mice against lethal aerosol or intranasal cow-pox virus challenge. The Journal of Infectious Diseases. 181:2000;10-19.
44. Crance J.M., Lamarque D., Scaramozzino N., Ferrier-Rembert A., Agay D., Garin D. Variole : la menace fantôme. Médecine et Armées. 30:(5):2002;495-502.
45. e édition médecine interne tome 2, 147 : variole, vaccine et autres poxvirus. Harrison éditeur. 1995;Mc Graw-Hill Libri Italia 20129, Milano Italie.
46. Lepine P. Variole - Vaccine in Techniques de laboratoire en virologie humaine. 1964;Masson & Cie, Paris.
47. Meyer H., Ropp S.L., Esposito J.J. Gene for a type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses. J Virol Methods. 64:(2):1997;217-221.
48. Ibrahim M.S., Esposito J.J., Jahrling P.B., Lofts R.S. The potential of 5' nuclease PCR for detecting a single-base polymorphism in orthopox-virus. Mol Cell Probes. 11:(2):1997;143-147.
49. Sandvik T., Tryland M., Hansen H., Mehl R., Moens U., Olsvik O., et al. naturally occuring orthopoxviruses: potential for recombination with vaccine vectors. J Clin Microbiol. 36:(9):1998;2542-2547.
50. Roop S.L., Jin Q., Knight J.C., Massung R.F., Esposito J.J. PCR strategy for identification and differenciation of smallpox and other orthopoxviruses. J Clin Microbiol. 33:(8):1995;2069-2076.
51. Loparev V.N., Massun R.F., Esposito J.J., Meyer H. detection and differentiation of old world orthopoxviruses: restriction fragment length polymorphism of crmb gene region. J Clin Microbiol. 39:(1):2001;94-100.
52. Garin D, CRSSA, BP 87, 38702 La Tronche Cedex (France). PCR quantitative (taqman PCR) pour orthopoxviruses (communication personnelle).
53. Interim guidance for use of smallpox vaccine, Cidofovir, and Vaccinia Immune Globulin (VIG) for prevention and treatment in the setting of outbreak of monkey-pox infections. Guidelines and resources, CDC. June 12, 2003;1-6.
54. De Clercq E. Cidofovir in the treatment of poxvirus infections. Antiviral Research. 55:2002;1-13.
55. Smee D.F., Sidwell R.W., Kefauver D., Bray M., Huggins J.W. Characterization of wild-type and cidofovir-resistant strains of camel-pox, cow-pox, monkey-pox and vaccinia viruses. Antimicrobial, Agents and Chemotherapy. may 2002;1329-1335.
56. De Clercq E. Vaccinia virus inhibition as a paradigm for the chemotherapy of pox infections. Clin.Microbiol rev. 14:(2):2001;382-397.
57. Ramirez C., Tapia E., Esteban M. Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions. Journal of General Virology. 83:2002;1059-1067.
58. Recommandations for using smallpox vaccine in the pre-event vaccination program: supplemantal recommandations of the advisory comittee on immunization practices (AICP) and the healthcare infection contral practices advisory committee (HICPAC). MMWR. 52:2003;1-16.
59. Neff J.M., Drachman R.H. Complications of smallpox vaccination, 1968. Surveillance in a comprehensive care clinic. Pediatrics. 50:1972;481-483.
60. Martin Bouyer C., Foulon G., De Solan M., et al. Étude des décès imputables à la vaccination antivariolique en France, de 1968 à 1977. Arch. Fr. Pediatr. 37:1980;199-206.
61. Interim infection control and exposure management guidance in the health-care and community. Setting for patients with possible monkey-pox virus infection. hhtp://www.cdc.gov/ncidod/monkeypox/infectioncontrol.htm.
62. Smallpox vaccination and adverse reactions : guide for clinicians. MMWR. 52:(rr-4):2003;1-28.
63. Notice to readers: supplemental recommendations on adverse events following smallpox vacine in the pre-event vaccination program: recommandations of the advisory committee on immunization practices (ACIP). MMWR. 52:(rr5):2003;29-30.
64. Redfield R., Wright D.C., James W.D. disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 316:1987;673-676.